NCT04416971|Unknown
Loading search results
Sponsor study identifier
observational
100
1 country
1
Study Start
August 20, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis(HD), and fistula-first is the general recommendation for all HD patients. But in clinical practice in China, quite a few patients start HD before AVF maturation due to various situations. Whether HD initiation with mature AVF will influence the patency and complications is controversial. This study is aim to compare the AVF patency in incident HD patients with mature or immature AVF on HD initiation, and to compare other clinical outcomes, including abandonment without use, infection, and other AVF complications occurrence.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 1, 2020
Actual (reported)June 4, 2020
Actual (reported)August 20, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
AVF patency
A functional AVF was defined as allowing at least six adequate HD sessions without any AVF-related complications. Primary AVF patency was defined as the interval from HD initiation via a functional AVF to any intervention designed for maintenance or reestablishment of AVF function, AVF failure, or study end, whichever occurred first, and secondary AVF patency was defined as the interval from HD initiation via an AVF until the termination of HD via AVF due to any cause, regardless of the number of subsequent interventions.
June 2020 to June 2021
Abandonment without use, infection, and other complications of AVF creation.
June 2020 to June 2021
Patients initiate HD with mature AVF.
Patients initiate HD with immature AVF.
For patients with mature/immature AVF on HD initiation, AVF puncture will be conducted.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
* aged 18 years and older * underwent initial upper-extremity AVF creation for incident HD at our hospital * divided into mature/immature AVF groups according to the AVF status on HD initiation
No.180, Fenglin Road, Xuhui District
Shanghai, Shanghai Municipality, 200032, China
bo shen, MD
Fudan University
First Submitted
June 1, 2020
First Posted
June 4, 2020
Study Start
August 20, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 20, 2021
Effectiveness and Health Economics of Endoluminal Treatment of Arteriovenous Graft Fistula.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 20, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 18, 2020
Record last verified: 2020-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: